11
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Chemotherapy with High-Dose Cytosine Arabinoside and Mitoxantrone for Poor-Prognosis Myeloid Leukemias

, , , , &
Pages 509-516 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Henry Fung, John D. Shepherd, Sheldon C. Naiman, Michael J. Barnett, Donna E. Reece, Douglas E. Horsman, Stephen H. Nantel, Heather J. Sutherland, John J. Spinelli, Hans-G. Klingman & Gordon L. Phillips. (1995) Acute Monocytic Leukemia: A Single Institution Experience. Leukemia & Lymphoma 19:3-4, pages 259-265.
Read now

Articles from other publishers (4)

Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Miguel Ángel Sanz & Pau Montesinos. (2018) Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review. Annals of Hematology 97:7, pages 1115-1153.
Crossref
Peter H. Wiernik. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 375 401 .
Yener Koc, Basak Oyan, Ayse Kars, Gulten Tekuzman, Hande Canpinar & Emin Kansu. (2004) A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia. Hematological Oncology 22:2, pages 43-53.
Crossref
Xing-Yue He, Paul Elson, Brad Pohlman, Alan Lichtin, Mohamad Hussein, Steve Andresen & Matt Kalaycio. (2002) Timed sequential chemotherapy with concomitant Granulocyte Colony-Stimulating Factor for high-risk acute myelogenous leukemia: a single arm clinical trial. BMC Cancer 2:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.